SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 48 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $1,001,000 | -75.3% | 409,000 | -80.2% | 0.29% | -75.0% |
| Q2 2014 | $4,045,000 | +12.0% | 2,061,000 | -3.7% | 1.15% | +8.0% |
| Q1 2014 | $3,612,000 | +1.9% | 2,140,000 | -9.4% | 1.07% | -1.7% |
| Q4 2013 | $3,546,000 | +21.9% | 2,362,000 | +0.3% | 1.09% | +14.4% |
| Q3 2013 | $2,908,000 | -3.5% | 2,355,000 | -6.5% | 0.95% | -11.0% |
| Q2 2013 | $3,012,000 | – | 2,518,000 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TENOR CAPITAL MANAGEMENT Co., L.P. | 36,001,000 | $95,697,000 | 16.53% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 145,320,992 | $386,133,000 | 6.28% |
| Verition Fund Management LLC | 18,500,000 | $49,268,000 | 5.72% |
| PIPER SANDLER & CO. | 3,750,000 | $9,968,000 | 4.14% |
| BERKLEY W R CORP | 25,881,000 | $68,886,000 | 3.58% |
| WOLVERINE ASSET MANAGEMENT LLC | 31,256,000 | $83,048,000 | 1.66% |
| TT INTERNATIONAL | 760,000 | $2,020,000 | 1.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 31,014,000 | $82,372,000 | 1.20% |
| CSS LLC/IL | 8,300,000 | $22,057,000 | 1.12% |
| SG Americas Securities, LLC | 370,000 | $98,536,000 | 0.59% |